← Back to Search

Cardiac Rehabilitation Group for Peripheral Arterial Disease

N/A
Waitlist Available
Led By Kamal Gupta, MD
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to up to 6 months
Awards & highlights
No Placebo-Only Group

Summary

The main purpose of this study is to see if it is safe and feasible to use cardiac rehabilitation (CR) in patients with peripheral arterial disease (PAD) after successful revascularization. This study will also test if CR improves quality of life and health outcomes in PAD patients.

Eligible Conditions
  • Peripheral Arterial Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in 6 minute walk test
Secondary study objectives
Absolute Claudication Distance (ACD)
Functional Claudication Distance (FCD)
Short Form Health Survey 36 (SF-36)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cardiac Rehabilitation GroupExperimental Treatment1 Intervention
Participants randomized to this group will undergo cardiac rehabilitation program.
Group II: Control GroupActive Control1 Intervention
Participants randomized to this group will receive care for their condition, conventional therapy, that they would normally receive.

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
510 Previous Clinical Trials
176,861 Total Patients Enrolled
3 Trials studying Peripheral Arterial Disease
272 Patients Enrolled for Peripheral Arterial Disease
Kamal Gupta, MDPrincipal InvestigatorUniversity of Kansas Medical Center
1 Previous Clinical Trials
115 Total Patients Enrolled
~3 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top